CIK: 0002111120 ยท Show all filings
Period: Q4 2025
Filing Date: Feb 17, 2026
Total Value ($000): $72,368 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BEAM | BEAM THERAPEUTICS INC | 1,266,934 | $35,119 | 48.5% | $25.51 | 0.0% | COM | 07373V105 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,008,116 | $31,030 | 42.9% | $22.38 | 0.0% | COM NEW | 55083R203 |
| PRME | PRIME MEDICINE INC | 1,792,210 | $6,219 | 8.6% | $4.45 | 0.0% | COM | 74168J101 |